PPD
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Growth Equity VC | ||
N/A | N/A | IPO | |
$17.4b Valuation: $17.4b | Acquisition | ||
$3.5b | Post IPO Debt | ||
Total Funding | - |
Recent News about PPD
EditPPD is a global contract research organization (CRO) that specializes in providing clinical research services to small to mid-sized biotech and pharmaceutical companies. The company operates in the healthcare and life sciences market, focusing on accelerating drug development through the integration of real-world data (RWD), predictive analytics, and AI-powered algorithms. PPD's business model revolves around offering comprehensive clinical research solutions, including study planning, data management, and regulatory compliance. The company generates revenue by partnering with clients to conduct clinical trials and providing actionable insights that enhance the efficiency and success rate of drug development programs. PPD leverages advanced technology and the services of Thermo Fisher Scientific to deliver high-quality, ethical, and compliant research outcomes.
Keywords: clinical research, drug development, biotech, pharma, real-world data, predictive analytics, AI algorithms, regulatory compliance, study planning, Thermo Fisher Scientific.